Contact this trialFirst, we need to learn more about you.
NMDA Receptor Antagonist
Perampanel + Ketamine for Suicidal Thoughts
Recruiting0 awardsPhase 2
West Haven, Connecticut
This trial looks at whether a drug called Ketamine can help treat depression and suicidal thoughts by affecting two types of receptors in the brain.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.